Hemodiafiltration

Hemodiafiltration (HDF) is an advanced dialysis method that combines both diffusion and convection principles. This allows the removal of both small and large molecules from the blood, offering more effective clearance of waste and toxins compared to conventional hemodialysis.

During this treatment, blood is purified through specialized filters and machines, removing both dissolved substances and larger molecules transported with fluid. Hemodiafiltration is particularly advantageous for eliminating uremic toxins and medium-to-low molecular weight proteins.

HDF is considered a safe and effective option for patients with chronic kidney failure and those at higher risk of dialysis-related complications. The treatment plan is determined by a nephrologist based on the patient’s overall health, kidney function, and fluid balance.

Who Is It Suitable For?

Hemodiafiltration is particularly suitable for patients with chronic kidney failure who are not adequately cleared by conventional hemodialysis. It is preferred when effective removal of medium and large molecular uremic toxins is required.

It is also an ideal option for patients at higher risk of dialysis-related complications and those who need more intensive blood purification. This helps reduce toxin accumulation and improve treatment effectiveness.

Suitability for each patient should always be determined by a nephrologist. The treatment plan is personalized based on the patient’s overall health, kidney function, and fluid balance.